TerminatedPhase 3

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Stopped: undefined

Mexico20 participantsStarted 2007-11

Plain-language summary

To Evaluate combined effect of vitrectomy and bevacizumab to stabilize retinal thickness and visual acuity in patients with diffuse diabetic macular edema and their relation to renal disease.

Who can participate

Age range25 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older than 25 yo * Diffuse diabetic macular edema with or without previous treatment Exclusion Criteria: * Another retinal disease * Pregnancy

What they're measuring

Retinal thickness

Timeframe: 3 months

Trial details

NCT IDNCT00571142

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-11

View on ClinicalTrials.gov More Diffuse Diabetic Macular Edema trials